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The neutrophil NADPH oxidase is an enzymatic complex involved in innate immunity. Phosphoryla-
tion of p47phox promotes its translocation with p67phox and p40phox, followed by membrane interac-
tion and assembly with ﬂavocytochrome b558 into a functional complex. To characterise p47phox
conformational changes during activation, we used wild-type and the S303/304/328E triple mutant
mimicking the phosphorylated state. Hydrogen/deuterium exchange and limited proteolysis cou-
pled to mass spectrometry were used to discriminate between the various structural models. An
increase in deuteration conﬁrmed that p47phox adopts an open andmore ﬂexible conformation after
activation. Limited proteolysis correlated this change with increased auto-inhibitory region (AIR)
accessibility. These results establish a structural link between the AIR release and the exposure of
the Phox homology (PX) domain.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The neutrophil NADPH oxidase complex has been widely stud-
ied over the past 30 years [1]. This multi-component complex is
the archetype for a recently expanded group of enzymes divided
into seven families named on the basis of the membranal redox
component: Nox1, Nox2, Nox3, Nox4, Nox5, Duox1 and Duox2
[2,3]. They are found in many cellular types and play different
physiological roles, for instance in microbicidal activity, hormone
synthesis and vascular tone control [3]. The neutrophil NADPH oxi-
dase complex (based on Nox2) is one of the ﬁrst barriers during the
nonspeciﬁc immune response. Its main role is the destruction ofchemical Societies. Published by E
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my of Sciences of the Czechphagocytosed pathogens through the superoxide anion O2 . The
reactive oxygen is produced by the oxidase complex in neutrophil-
ic vacuoles by transferring electrons from the NADPH donor to
molecular oxygen. The importance of this complex is illustrated
by the occurrence of chronic granulomatous disease (CGD) upon
mutation(s) of one of its components.
The overall assembly process of this membranal complex has
already been thoroughly studied [1,4]. However, its activation
and regulation still need to be clearly elucidated. The catalytic core
of the NADPH oxidase complex is represented by ﬂavocytochrome
b558. It enables electron transfer and is composed of two mem-
brane proteins, Nox2 and p22phox. The other parts of the complex
are cytosolic proteins: p40phox, p67phox, p47phox and Rac(1 or 2), a
small G protein. Except for Rac, these proteins undergo phosphory-
lations during the NADPH oxidase activation [5,6]. Upon phosphor-
ylation, all cytosolic factors translocate to the membrane-bound
catalytic core, which triggers the activation of the whole assembly.
Due to their modular nature, p40phox, p67phox and p47phox have
been reluctant to crystallisation trials and X-ray structure determi-
nation. Finally, the structure of the entire p40phox has been recently
released [7], while the structures of the entire p67phox and p47phox
remain unknown. Therefore, structural and functional studies on
these two proteins have long been conducted using their isolatedlsevier B.V. All rights reserved.
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mine whether it plays a role as a complex organiser triggered by
its activation. Based on structural data obtained with isolated mod-
ules, a model for the activation of p47phox was proposed [6,10,15].
According to these studies, p47phox exists as an auto-inhibited form
in the resting state. The auto-inhibition state has been explained
by intramolecular interactions between the Phox homology (PX)
domain and the SH3B [16,17] and between the tandem SH3s and
an auto-inhibiting region (AIR) [9,12,18]. During activation, these
modules are believed to be unmasked, enabling PX domain interac-
tion with membrane anionic phospholipids [10,19] and the tandem
SH3s interaction with the p22phox C-terminus [13,14]. However,
this model seems unlikely because the second SH3B cannot interact
with the PX and the AIR at the same time, since both partners
would use the same binding site [9,17].
Our group recently presented a revised model based on small-
angle X-ray scattering (SAXS) studies of the entire protein, showing
that the p47phox auto-inhibited form was more elongated than ex-
pected [20]. This new model suggests that the AIR binds to the tan-
dem SH3s and proposes a new interaction mode for the PX domain
with both SH3A and the AIR. At this stage, additional data are re-
quired to conﬁrm and reﬁne the details of the auto-inhibited mod-
el but also to describe the molecular rearrangements occurring
upon p47phox activation.
In this study, we used wild-type auto-inhibited p47phox and a
triple mutant (S303/304/328E) known to mimic the phosphory-
lated activated form of p47phox [9,10,15,21,22]. Using H/D ex-
change coupled to mass spectrometry, we followed solvent
accessibility and ﬂexibility modiﬁcations occurring upon confor-
mational changes from the resting to the activated state. In addi-
tion, limited proteolysis identiﬁed modiﬁcations in the AIR’s
susceptibility to cleavage. Based on the results presented herein,
we established a structural link between the simultaneous releases
of the AIR and PX in a p47phox construct integrating all the func-
tional modules involved in the activation process.2. Materials and methods
2.1. Materials
Glutathione Sepharose high-performance and SP Sepharose
high-performance columns came from GE Healthcare. The Jupiter
5 lm C18 column (50  1.00 mm; 300 Å) was from Phenomenex.
Protein MacroTrap (C8) was purchased from Michrom
Bioresources.
The following products were purchased from Avanti Polar
Lipids: 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleyl-sn-glycero-3-phosphoethanolamine (POPE),
1-palmitoyl-2-oleyl-sn-glycero-3-phosphate (POPA) and 1,2-diol-
eoyl-sn-glycero-3-[phosphoinositol-3,4-biphosphate] (PtdIns (3,
4)P2).
2.2. p47phox cloning, expression and puriﬁcation
cDNA encoding p47phox residues 1–342 was cloned into pGex-
6P vector adding an N-terminal glutathione S-transferase (GST) fu-
sion tag. After GST cleavage, 10 additional residues remained at the
N-terminus of the protein. These additional residues will be re-
ferred to as negative numbers in peptide numbering and the
resulting p47phox (10–342) construct as p47phoxDCter. The triple
mutation S303/304/328E was introduced by PCR-mediated site-di-
rected mutagenesis, leading to the form mimicking the activated
p47phox, referred to as p47phoxTM-DCter. The proteins were ex-
pressed in Escherichia coli BL21(DE3) and puriﬁed according to
Durand et al. [20].2.3. Binding the PX domain to multi-lamellar vesicles (MLV)
The in vitro semi-quantitative liposome-binding assay was
adapted from Ago et al. [16] with minor modiﬁcations. Liposomes
were prepared by mixing POPC and POPE (50:50) for the control
(MLV1) and POPC, POPE, POPA and PtdIns(3,4)P2 (45:45:5:5) for
speciﬁc liposomes (MLV2). The mixture was then dried under
nitrogen and resuspended to a concentration of 2 mM of total lip-
ids in a binding buffer (20 mM Tris, pH 7.4, 100 mM NaCl, 1 mM 1-
4, dithiothreitol (DTT)). After 2 h of incubation on ice, liposomes
were obtained by vortexing. Proteins (5 lM) were incubated with
liposomes (1 mM) for 15 min at 20 C in 100 lL binding buffer. Lip-
osomes were collected by ultracentrifugation (45 min at
49000 rpm in a TLA 100.4 rotor) and aliquots were taken for fur-
ther analysis by 12% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE). Coomassie Blue-stained gels were
scanned and analysed by densitometry. Three independent exper-
iments were conducted.
2.4. Limited proteolysis analysis
Chymotrypsin and trypsin were chosen among other proteases
(elastase, thermolysin) by SDS–PAGE digestion pattern screening.
Aliquots (5 lg/well) were taken at 15 min, 30 min, 1 h, 2 h and
3 h and the different protein/enzyme ratios were analysed. p47phox
incubation with 0.5‰ chymotrypsin or trypsin at 20 C displayed
signiﬁcant differences between p47phoxDCter and p47phoxTM-
DCter digestion patterns (Fig. 3).
The p47phox digests were loaded onto a Protein MacroTrap and
desalted with 0.03% TFA for 1 min. The peptides were eluted on a
C18 column and separated by a three-step elution (5 min at 35%
acetonitrile (ACN), 10 min at 45% ACN and 2 min at 100% ACN).
The column was directly interfaced to an ESI-TOF-MS (Agilent).
The most representative digestion times were reported here (1 h
and 3 h for trypsin and chymotrypsin, respectively). The masses
of detected peptides were searched for against the p47phox se-
quence using the FindPept software.
2.5. Global H/D exchange kinetics
The exchange of p47phoxDCter and p47phoxTM-DCter was initi-
ated by a 20-fold dilution in a deuterated buffer (5 mM HEPES,
pD 7.4, 1 mM EDTA, 2 mM DTT and 200 mM NaCl). Aliquots
(40 ll) were taken after 10 s, 30 s, 1 min, 5 min, 10 min, 30 min,
1 h, 3 h, 5 h, 7 h and 9 h. The exchange was quenched by adding
5.6 lL of 50 mM HCl and rapid freezing in liquid nitrogen. Next,
each sample was quickly thawed, online desalted on Protein Mac-
roTrap, eluted with 70% ACN and analysed using ESI-TOF-MS. The
spectra were smoothed and deconvoluted with Magtran software
[23]. Deuteration levels were calculated according to Zhang and
Smith [24]. Three independent measurements were taken.3. Results and discussion
3.1. p47phoxDCter and p47phoxTM-DCter are representative of the
resting and activated states of full-length p47phox
Conformational changes that occur during p47phox phosphory-
lation promote new interactions with membrane lipids and
p22phox membrane protein [10,14,19]. The PX domain, the tandem
SH3s and the AIR are directly involved in these interaction prop-
erty changes. On the contrary, the C-terminal region of p47phox
(343–390) is only required for p67phox and p40phox interaction,
allowing their co-translocation to the membrane [25,26]. In addi-
tion, this C-terminal region of p47phox is not involved in binding
Fig. 2. Deuteration kinetics for p47phoxDCter (d) and p47phoxTM-DCter (s) at pD
7.4. The inset is a replot of the curves on the logarithmic scale.
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binant form of p47phox is well expressed but is unstable due to the
high protease sensitivity of its C-terminal region during puriﬁca-
tion. Therefore, to avoid heterogeneity of the sample, a C-terminal
truncated form of p47phox (p47phoxDCter) was used. It contains all
the structural elements involved in the locking of p47phox in its
resting state. Using NMR and CD spectroscopy, Shen et al. [27] have
recently demonstrated that such C-terminal truncation does not
induce global or domain unfolding.
It was previously shown that mutations of serines 303, 304 and
328 into glutamates were sufﬁcient to mimic their phosphoryla-
tion and the transition from a resting to an activated state. These
mutated forms were shown to bind membranes and p22phox with
a greater afﬁnity than p47phox [10,15,16]. Moreover, they induce
the O2 production by the whole NADPH oxidase complex [21].
The truncated triple mutant S303/304/328E, p47phoxTM-DCter,
was generated as a model of activated p47phox. The existence of
two distinct conformations, with increased ﬂexibility in the acti-
vated state, has been suggested to account for the interaction with
the membrane [15]. To conﬁrm this hypothesis and demonstrate
the functionality of the construct, p47phoxDCter and p47phoxTM-
DCter were ﬁrst incubated with nonspeciﬁc and speciﬁc liposomes,
with BSA as a negative control. As expected, none of the proteins
bound to nonspeciﬁc vesicles (MLV1, bound/unbound <0.5); BSA
did not interact with any vesicles (Fig. 1). In contrast, both
p47phoxDCter and p47phoxTM-DCter interacted with liposomes
containing 5% PI(3,4)P2 (MLV2), but at different levels. Interest-
ingly, the weak interaction of p47phoxDCter shows that the auto-
inhibited conformation is not locked as tightly as has often been
suggested. This basal interaction of the p47phoxDCter form with
lipids was also observed in similar pull-down experiments and
suggests an equilibrium between two different conformations
(closed and open) [10,16,27]. Interaction was greater for
p47phoxTM-DCter (bound/unbound = 14.7 ± 0.2) than for the
p47phoxDCter (bound/unbound = 6.4 ± 0.6). This stronger interac-
tion between p47phoxTM-DCter and MLV2 clearly shows its acti-
vated conformation. The membrane-binding ratio increase for the
activated state of p47phox agrees with previous reports by otherFig. 1. Phosphoinositide-binding activity of p47phoxDCter and p47phoxTM-DCter vs
negative control, BSA. p47phoxDCter, p47phoxTM-DCter or BSA were incubated with
liposomes containing POPC:POPE 50:50 (MLV1) or POPC:POPE:POPA:PtdIns(3,4)P2
45:45:5:5 (MLV2). S and P are liposomal supernatant and pellet after centrifugation,
corresponding to the unbound and bound fraction, respectively. Samples were
analysed by SDS–PAGE and quantiﬁed by densitometry.groups [10,16], conﬁrming that the mutations introduced favor a
more open conformation and increased access to the PX module.
3.2. The activated state of p47phox presents an increased solvent
accessible surface and ﬂexibility
Until now, the activated state of the entire p47phox has been de-
ﬁned as an open state, as demonstrated by functional studies [15].
Indeed, the structural data obtained so far have always been deter-
mined on isolated modules leading to inconsistent sets of data
regarding the locking mechanism of the entire protein, as de-
scribed previously [20]. To structurally describe the potential con-
formational events occurring in the whole protein upon activation,
we followed the time course of deuteration for both p47phox forms.
This technique is today widely used to better characterise non-Fig. 3. SDS–PAGE of p47phoxDCter and p47phoxTM-DCter proteolysis with 0.5‰
chymotrypsin (A) and trypsin (B).
838 J. Marcoux et al. / FEBS Letters 583 (2009) 835–840crystallizing protein and protein dynamics or interactions
[24,28,29]. The deuteration kinetics showed a signiﬁcant difference
between p47phoxDCter and p47phoxTM-DCter proteins (Fig. 2).
Higher deuteration levels of p47phoxTM-DCter that are already vis-
ible after few seconds of exchange (inset, Fig. 2) could be inter-
preted as ‘‘opening” the protein, resulting in an increase in the
surface exposed to the solvent. The steady increase in the differ-
ence between p47phoxDCter and p47phoxTM-DCter may also point
to another change: higher structural ﬂexibility of the activated
form. These global deuteration kinetics are the ﬁrst experimental
evidence of structural differences between the auto-inhibited and
activated forms of p47phox.
3.3. Upon activation, the AIR goes from a hindered to an exposed state
Local information on structural differences can be obtained by
limited proteolysis, as is commonly used for protein domain deter-
mination [30]. The digestion time course was followed with 0.5‰
trypsin or chymotrypsin. Aliquots were collected at the times indi-
cated above and all samples were resolved on SDS–PAGE (Fig. 3).
Direct visual inspection of Coomassie Blue-stained gels clearly
showed lower molecular-weight bands for p47phoxTM-DCter than
for p47phoxDCter, reﬂecting better protease accessibility and sug-
gesting a more open and/or ﬂexible conformation for the activated
form. LC-ESI-TOF analysis of p47phoxDCter digested with 0.5‰ chy-Fig. 4. Deconvoluted ESI-TOF mass spectra of p47phoxDCter (A) and p47phoxTM-
DCter (B) after 3 h of digestion with chymotrypsin at 0.5‰. Annotations show ﬁrst
and last amino acids of each peptide detected.motrypsin supported these ﬁndings by identifying the two major
masses corresponding to the 10–139 and 140–342 peptides
(Fig. 4A). However, more than two peaks were obtained after
digestion of p47phoxTM-DCter (Fig. 4B). Twomajor peaks again cor-
responded to the 10–139 and 140–342 peptides while other
peaks matched the 10–324, 10–331, 140–324 and 140–331
peptides. Trypsin limited proteolysis (0.5‰) generated more pep-
tides than chymotrypsin after 1 h (see supplementary data). We
identiﬁed 19 peaks for each protein (Table 1) generated through
12 cleavage sites. From the trypsin and chymotrypsin digests, four
common cleavage sites were identiﬁed: Arg85, Tyr139, Lys143 and
Lys146. We also found speciﬁc cleavage sites after Arg335/336/337
for p47phoxDCter and after Arg292/296/314/316/318, Lys295, Tyr324 and
Phe331 for p47phoxTM-DCter.
These common sites are easily explained by our model. Tyrosine
139 and lysines 143 and 146 are situated in a linker region be-
tween the PX domain and the SH3 tandem expected to be unstruc-
tured and highly ﬂexible (Fig. 5) [20]. However, this region has
recently been suggested to be involved in the activation process
and more precisely to play an active role in maintaining the
auto-inhibited conformation [27]. If different structural states of
this linker exist in both p47phox forms, this approach cannot dis-
criminate them. The fourth common site, Arg85, is located at the
beginning of a loop linking two helices in the PX structure [10],
whereas the other lysines and arginines from PX belong to second-
ary structure elements. Thus, only Arg85 is accessible by trypsin in
the PX domain. The existence of this cleavage site in both p47phox
forms suggests that this side of the PX is always accessible and
probably not involved in a locking interaction in the auto-inhibited
form.
The speciﬁc cleavage sites, Arg335,336,337, are situated in the ﬂex-
ible C-terminal part of p47phox downstream of the AIR, whichTable 1
Identiﬁed peptides after digestion of p47phoxDCter and p47phoxTM-DCter with 0.5‰
trypsin or chymotrypsin (experimental masses and mass errors are given).
Limited proteolysis
p47phoxDCter p47phoxTM-DCter
Exp. mass Sequence Exp. mass Sequence
From To ppm From To ppm
Trypsin
40399.7 10 342 17 37541.54 10 318 13
39890.03 10 337 14 37257.74 10 316 21
39733.58 10 336 8 37014.65 10 314 22
39577.42 10 335 8 36604.66 1 318 99
39462.68 1 342 17 36320.65 1 316 14
38952.92 1 337 12 36077.41 1 314 23
38796.05 1 336 5 34908.12 10 296 20
38640.62 1 335 14 34752.1 10 295 27
28700.65 86 337 7 34382.76 10 292 22
28388.28 86 335 7 33971.29 1 296 21
21736.55 147 337 53 33445.46 1 292 17
21723.05 144 335 13 18860.38 147 314 25
21422.84 147 335 8 18172.36 10 146 16
18172.33 10 146 12 17872.17 10 143 23
17872.19 10 143 20 17235.43 1 146 24
17235.48 1 146 19 16934.87 1 143 9
16934.9 1 143 12 16228.42 147 292 20
11206.87 10 85 1 11206.88 10 85 9
10270.31 1 85 31 10270.56 1 85 59
Chymotrypsin
40398.43 10 342 15 40523.92 10 342 30
23014.64 140 342 12 39176.46 10 331 29
17402.33 10 139 12 38218.29 10 324 32
23140.56 140 331 20
21793.17 140 342 14
20835.08 140 324 15
17401.34 10 139 45
Fig. 5. Schematic representation of the cleavage sites obtained after digestion with
0.5‰ trypsin and chymotrypsin. Common sites are represented with solid arrows
and speciﬁc sites for p47phoxDCter and p47phoxTM-DCter with dashed arrows. AIR,
auto-inhibiting region (represented in black).
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these cleavage sites in p47phoxDCter, such as 1–335, 1–336 and 1–
337, are not present when digesting the p47phoxTM-DCter because
the tryptic proteolysis went further and generated shorter pep-
tides, such as 1–316, 1–314 or 1–292. Moreover, all eight speciﬁc
cleavage sites (Arg292/296/314/316/318, Lys295, Tyr324 and Phe331) of
p47phoxTM-DCter are part of the AIR. This domain was shown to
be implicated in the auto-inhibition of tandem SH3s [9] and we
conﬁrm here that it is more accessible and ﬂexible in the
p47phoxTM-DCter activated state.
3.4. Conclusion and perspectives
This study compared two conformational states of p47phox that
play a key role in the activation process of the neutrophil NADPH
oxidase. The global H/D exchange kinetics revealed a signiﬁcant
difference in deuteration between the two constructs, which can
be interpreted as an increase in both solvent accessibility and
structural ﬂexibility of the activated form. This was further sup-
ported by limited proteolysis of p47phoxDCter and p47phoxTM-
DCter, identifying eight extra cleavage sites in the AIR of
p47phoxTM-DCter. To our knowledge, this work is the ﬁrst struc-
tural approach on a p47phox form integrating all the modules in-
volved in its auto-inhibition. It conﬁrms the existence of
conformational changes between the inhibited and activated
forms. We demonstrated that incorporation of negative charges
in positions 303, 304 and 328 results in the release of the AIR from
a hindered to an accessible state. This conﬁrms that the AIR and the
tandem SH3s form a super-complex in auto-inhibited p47phox, as
has previously been hypothesised from structural analysis on iso-
lated domains [9]. Furthermore, enhancement of the PX–lipid
interaction is associated with the AIR release, conﬁrming the need
for a well-constituted ‘‘tandem SH3s-AIR super-complex” for PX
locking. From our previously described SAXS-derived envelope of
the entire p47phox, the PX domain can only ﬁt laterally to this ‘‘tan-
dem SH3s-AIR super-complex” in the auto-inhibited state [20].
Altogether, this suggests that there are contacts between the PX
and parts of this super-complex (Fig. 5). This model is in full agree-
ment with the behaviour of the W263R mutation in the tandemSH3s, as previously described [10]. This mutation is an alternate
way to generate a lipid-binding activated state of p47phox. Indeed,
in this mutant, exaltation of the PX properties may result from the
initial disruption of the ‘‘tandem SH3s–AIR super-complex”. In
accordance with this view, a recent in vivo study has contributed
new data arguing in favor of this type of organisation [22].
A complete characterisation of the p47phox auto-inhibitory orga-
nisation would require the identiﬁcation of an interaction interface
between the PX domain and the SH3A domain and/or loop(s) with-
in the AIR. The difference observed during global deuteration
kinetics opens the way to local hydrogen/deuterium exchange
kinetics so that the spatial resolution of these results can be in-
creased considerably [24,28,29]. This approach is particularly well
suited to identifying such interfaces and is currently underway.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2009.01.046.
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